Thanh Ho

Dr. Thanh Ho

Northeastern Univerisity
orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 August 2016 in Organic Letters
Verified
Journal Article
Open access
THThanh Ho
Thanh Ho
HKHaruki Kamimura
Haruki Kamimura
KOKen Ohmori
Ken Ohmori
KSKeisuke Suzuki
Keisuke Suzuki
The bis-C-glucosyl flavonoid vicenin-2 (1) has been synthesized by exploiting bis-C-glycosylation of 1,3,5-trifluorobenzene and aromatic nucleophilic substitution to transform fluorine atoms to oxygen functions in excellent yield.

Verified
Journal Article
Open access
PDF file
DSDimitris Spyridakos
Dimitris Spyridakos
NMNiki Mastrodimou
Niki Mastrodimou
KVKiran Vemuri
Kiran Vemuri
THThanh Ho
Thanh Ho
Spyros NikasSpyros Nikas
Spyros Nikas
KTKyriaki Thermos
Kyriaki Thermos
Oxidative stress, neurodegeneration, neuroinflammation, and vascular leakage are believed to play a key role in the early stage of diabetic retinopathy (ESDR). The aim of this study was to investigate the blockade of cannabinoid receptor 1 (CB1R) and activation of cannabinoid receptor 2 (CB2R) as putative therapeutics for the treatment of the early toxic events in DR. Diabetic rats [streptozotocin (STZ)-induced] were treated topically (20 μL, 10 mg/mL), once daily for fourteen days (early stage DR model), with SR141716 (CB1R antagonist), AM1710 (CB2R agonist), and the dual treatment SR141716/AM1710. Immunohistochemical-histological, ELISA, and Evans-Blue analyses were performed to assess the neuroprotective and vasculoprotective properties of the pharmacological treatments on diabetes-induced retinal toxicity. Activation of CB2R or blockade of CB1R, as well as the dual treatment, attenuated the nitrative stress induced by diabetes. Both single treatments protected neural elements (e.g., RGC axons) and reduced vascular leakage. AM1710 alone reversed all toxic insults. These findings provide new knowledge regarding the differential efficacies of the cannabinoids, when administered topically, in the treatment of ESDR. Cannabinoid neuroprotection of the diabetic retina in ESDR may prove therapeutic in delaying the development of the advanced stage of the disease.

1 May 2008 in Tetrahedron
Verified
Journal Article
Closed access
LPLawrence M. Pratt
Lawrence M. Pratt
OKOhyun Kwon
Ohyun Kwon
THThanh Ho
Thanh Ho
NNNgan Van Nguyen
Ngan Van Nguyen

17 July 2017 in The Journal of Organic Chemistry
Verified
Journal Article
Closed access
THThanh Ho
Thanh Ho
NSNaoyuki Shimada
Naoyuki Shimada
MTMarcus A. Tius
Marcus A. Tius
SNSpyros P. Nikas
Spyros P. Nikas
WZWen Zhang
Wen Zhang
AMAlexandros Makriyannis
Alexandros Makriyannis

1 October 2019 in Molecules
Verified
Journal Article
Open access
PDF file
SAShakiru O. Alapafuja
Shakiru O. Alapafuja
Spyros NikasSpyros Nikas
Spyros Nikas
THThanh Ho
Thanh Ho
FTFei Tong
Fei Tong
OBOthman Benchama
Othman Benchama
AMAlexandros Makriyannis
Alexandros Makriyannis
In earlier work, we reported a novel class of CB2 selective ligands namely cannabilactones. These compounds carry a dimethylheptyl substituent at C3, which is typical for synthetic cannabinoids. In the current study with the focus on the pharmacophoric side chain at C3 we explored the effect of replacing the C1′-gem-dimethyl group with the bulkier cyclopentyl ring, and, we also probed the chain’s length and terminal carbon substitution with bromo or cyano groups. One of the analogs synthesized namely 6-[1-(1,9-dihydroxy-6-oxo-6H-benzo[c]chromen-3-yl) cyclopentyl] hexanenitrile (AM4346) has very high affinity (Ki = 4.9 nM) for the mouse CB2 receptor (mCB2) and 131-fold selectivity for that target over the rat CB1 (rCB1). The species difference in the affinities of AM4346 between the mouse (m) and the human (h) CB2 receptors is reduced when compared to our first-generation cannabilactones. In the cyclase assay, our lead compound was found to be a highly potent and efficacious hCB2 receptor agonist (EC50 = 3.7 ± 1.5 nM, E(max) = 89%). We have also extended our structure-activity relationship (SAR) studies to include biphenyl synthetic intermediates that mimic the structure of the phytocannabinoid cannabinodiol.

6 February 2020 in Molecules
Verified
Journal Article
Open access
PDF file
YLYingpeng Liu
Yingpeng Liu
THThanh Ho
Thanh Ho
MBMohammed Baradwan
Mohammed Baradwan
MLMaria Pascual Lopez-Alberca
Maria Pascual Lopez-Alberca
CTChristos Iliopoulos Tsoutsouvas
Christos Iliopoulos Tsoutsouvas
AMAlexandros Makriyannis
Alexandros Makriyannis
A new approach to synthesize cannabilactones using Suzuki cross-coupling reaction followed by one-step demethylation-cyclization is presented. The two key cannabilactone prototypes AM1710 and AM1714 were obtained selectively in high overall yields and in a lesser number of synthetic steps when compared to our earlier synthesis. The new approach expedited the synthesis of cannabilactone analogs with structural modifications at the four potential pharmacophoric regions.